Chicago Partners Investment »

Janux Therapeutics shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2024-12-31 $235k 4.6k 50.82
2024-09-30 $272k 5.3k 51.75
2024-03-31 $421k 8.5k 49.78
2022-09-30 $181k 11k 17.04
2021-12-31 $188k 11k 16.52
2021-09-30 $235k 9.5k 24.85

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Equity Market (DFUS)
Energy Transfer Com Ut Ltd Ptn (ET)
Enterprise Products Partners (EPD)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Innovator Etfs Trust Quity Managd Flr (SFLR)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Blackstone Group Inc Com Cl A (BX)

View all positions for Chicago Partners Investment

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
Adage Capital Partners GP
BlackRock
Paradigm Biocapital Advisors
Vanguard Group
Cormorant Asset Management
Woodline Partners
EcoR1 Capital
Citadel Advisors
Holocene Advisors
State Street Corporation
Lord, Abbett & Co
Logos Global Management

View all funds holding Janux Therapeutics